RainDance Technologies Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:RainDance Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6623
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; and consumables and next-generation sequencing enrichment solutions, among others. It also provides RainDrop Plus digital PCR systems an unified platform for NGS amplicon enrichment and digital PCR. RDT’s consumables include sense chips, source chips, and oil surfactants. RDT offers its products to academic and translational research institutions, agricultural and industrial clients, pharmaceutical and biotechnology companies, bio-banks, commercial laboratories, cancer centers and government institutions. The company distributes its products through a network of distributors located across Asia Pacific and EMEA regions. RDT is headquartered in Billerica, Massachusetts, the US.

RainDance Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RainDance Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RainDance Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
RainDance Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RainDance Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
RainDance Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
RainDance Technologies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 10
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
Partnerships 15
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
Equity Offering 17
RainDance Withdraws IPO for USD60 Million 17
Acquisition 18
Bio-Rad Labs Acquires RainDance Technologies 18
RainDance Technologies Inc – Key Competitors 19
RainDance Technologies Inc – Key Employees 20
RainDance Technologies Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Legal and Regulatory 22
Jan 20, 2017: 10x Genomics Invalidates RainDance Technologies Patent 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
RainDance Technologies Inc, Medical Equipment, Key Facts 2
RainDance Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
RainDance Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RainDance Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
RainDance Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RainDance Technologies Inc, Deals By Market, 2012 to YTD 2018 8
RainDance Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 10
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
RainDance Withdraws IPO for USD60 Million 17
Bio-Rad Labs Acquires RainDance Technologies 18
RainDance Technologies Inc, Key Competitors 19
RainDance Technologies Inc, Key Employees 20

List of Figures
RainDance Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
RainDance Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
RainDance Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
RainDance Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
RainDance Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
RainDance Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
RainDance Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
RainDance Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[RainDance Technologies Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yue Yuen Industrial (Holdings) Limited:企業の戦略・SWOT・財務情報
    Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • LM Wind Power Holding AS-エネルギー分野:企業M&A・提携分析
    Summary LM Wind Power Holding AS (LM Wind Power), a subsidiary of General Electric Co, is a component supplier to the wind industry. The company designs and manufactures blades on modular technology featuring modular aerodynamics, modular structure and modular manufacturing tooling. Its blades have …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, libromide, somulose, vetoryl, rapidexon, octacillin, domidine …
  • Arkle Resources Plc
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Healx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Healx Ltd (Healx) is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company’s technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. …
  • Mentor Graphics Corporation (MENT):企業の財務・戦略的SWOT分析
    Mentor Graphics Corporation (MENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Gerdau S.A.:戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China National Petroleum Corporation:企業の戦略・SWOT・財務分析
    China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Manulife Financial Corporation:戦略・SWOT・企業財務分析
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. …
  • Guararapes Confeccoes SA:企業の戦略・SWOT・財務情報
    Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report Summary Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BDO International Limited:企業の戦略・SWOT・財務分析
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Engie Brasil Energia SA (EGIE3):電力:M&Aディール及び事業提携情報
    Summary Engie Brasil Energia SA (Engie Brasil), formerly Tractebel Energia SA, a subsidiary of Engie SA, undertakes the generation and commercialization of electricity. It generates energy through various source of energy such as hydro; thermal; and complementary energy sources including wind, solar …
  • Max Hamburgerrestauranger AB:戦略・SWOT・企業財務分析
    Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report Summary Max Hamburgerrestauranger AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • GH Armor Systems Inc.:企業の戦略・SWOT・財務情報
    GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆